{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:34:38Z","timestamp":1778776478771,"version":"3.51.4"},"reference-count":171,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007446","name":"King Khalid University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007446","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023674","name":"King Khalid University Deanship of Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.yexcr.2025.114619","type":"journal-article","created":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:37:47Z","timestamp":1748651867000},"page":"114619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Beyond TRAIL resistance: Novel strategies for potentiating TRAIL-induced apoptosis in cancer"],"prefix":"10.1016","volume":"450","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8453-0142","authenticated-orcid":false,"given":"Jitendra","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein Salim","family":"Abed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subasini","family":"Uthirapathy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashishkumar","family":"Kyada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safia Obaidur","family":"Rab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3134-8711","authenticated-orcid":false,"given":"Debasish","family":"Shit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6367-1336","authenticated-orcid":false,"given":"Bethanney","family":"Janney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak","family":"Nathiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abed J.","family":"Kadhim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0926-7428","authenticated-orcid":false,"given":"Yasser Fakri","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yexcr.2025.114619_bib1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41374-019-0365-z","article-title":"Regulation of pancreatic cancer TRAIL resistance by protein O-GlcNAcylation","volume":"100","author":"Yang","year":"2020","journal-title":"Lab. Invest."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1871520623666221114095733","article-title":"Trailing TRAIL resistance in human breast adenocarcinoma cells with Trichostatin A and Zebularine","volume":"23","author":"Wong","year":"2023","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/etm.2023.11830","article-title":"Tobacco nicotine promotes TRAIL resistance in lung cancer through SNHG5","volume":"25","author":"Xiao","year":"2023","journal-title":"Exp. Ther. Med."},{"issue":"23","key":"10.1016\/j.yexcr.2025.114619_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316596","article-title":"TRAIL-sensitizing effects of flavonoids in cancer","volume":"24","author":"Luiz-Ferreira","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071062","article-title":"Behind the adaptive and resistance mechanisms of cancer stem cells to TRAIL","volume":"13","author":"Quiroz-Reyes","year":"2021","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.yexcr.2025.114619_bib6","doi-asserted-by":"crossref","first-page":"6470","DOI":"10.1002\/jcp.26585","article-title":"Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL","volume":"233","author":"Hassanzadeh","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"11\u201312","key":"10.1016\/j.yexcr.2025.114619_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s10495-022-01774-5","article-title":"Escaping cell death via TRAIL decoy receptors: a systematic review of their roles and expressions in colorectal cancer","volume":"27","author":"Jong","year":"2022","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3892\/or.2015.4463","article-title":"\u03b2-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer","volume":"35","author":"Ouyang","year":"2016","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biom11040572","article-title":"Overcoming TRAIL resistance for glioblastoma treatment","volume":"11","author":"Deng","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3892\/ijo.2016.3525","article-title":"Overcoming resistance to TRAIL-induced apoptosis in solid tumor cells by simultaneously targeting death receptors, c-FLIP and IAPs","volume":"49","author":"Huang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib11","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10495-017-1375-1","article-title":"Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)","volume":"22","author":"Rathore","year":"2017","journal-title":"Apoptosis"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00109-022-02180-9","article-title":"EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma","volume":"100","author":"Su","year":"2022","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/ERC-17-0479","article-title":"IAPs cause resistance to TRAIL-dependent apoptosis in follicular thyroid cancer","volume":"25","author":"Werner","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114619_bib14","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1007\/s13277-016-4816-5","article-title":"Trichostatin A potentiates TRAIL-induced antitumor effects via inhibition of ERK\/FOXM1 pathway in gastric cancer","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114619_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.febslet.2015.02.026","article-title":"Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells","volume":"589","author":"Liu","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2025.114619_bib16","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.12659\/MSM.903552","article-title":"Kaempferol sensitizes human ovarian cancer cells-OVCAR-3 and SKOV-3 to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-Induced apoptosis via JNK\/ERK-CHOP pathway and up-regulation of death receptors 4 and 5","volume":"23","author":"Zhao","year":"2017","journal-title":"Med. Sci. Monit."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11033-021-06778-z","article-title":"Kaempferol sensitizes tumor necrosis factor-related apoptosis-inducing ligand-resistance chronic myelogenous leukemia cells to apoptosis","volume":"49","author":"Saraei","year":"2022","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jmf.2023.K.0180","article-title":"The Antiobesity effects and potential mechanisms of Theaflavins","volume":"27","author":"Fang","year":"2024","journal-title":"J. Med. Food"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib19","doi-asserted-by":"crossref","first-page":"9689","DOI":"10.1007\/s00210-024-03101-y","article-title":"Fisetin reduces the resistance of MOLT-4 and K562 cells to TRAIL-induced apoptosis through upregulation of TRAIL receptors","volume":"397","author":"Liu","year":"2024","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28010264","article-title":"Isolation of various flavonoids with TRAIL resistance-overcoming activity from Blumea lacera","volume":"28","author":"Manome","year":"2022","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1631\/jzus.B2000497","article-title":"Traditional Chinese medicines and their active ingredients sensitize cancer cells to TRAIL-induced apoptosis","volume":"22","author":"Sun","year":"2021","journal-title":"J. Zhejiang Univ. - Sci. B"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/gt.2013.88","article-title":"TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice","volume":"21","author":"Deng","year":"2014","journal-title":"Gene Ther."},{"issue":"11","key":"10.1016\/j.yexcr.2025.114619_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ph15111391","article-title":"Human umbilical cord MSC delivered-soluble TRAIL inhibits the proliferation and promotes apoptosis of B-ALL cell in vitro and in vivo","volume":"15","author":"Chen","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/abbs\/gmu024","article-title":"Human mesenchymal stem cells with adenovirus-mediated TRAIL gene transduction have antitumor effects on esophageal cancer cell line Eca-109","volume":"46","author":"Li","year":"2014","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2025.114619_bib25","volume":"vol. 233","author":"Shi","year":"2020"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114619_bib26","first-page":"1512","article-title":"Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL\/Apo2L) and doxorubicin using micellar nanoparticles","volume":"7","author":"Lee","year":"2011"},{"key":"10.1016\/j.yexcr.2025.114619_bib27","volume":"174","author":"Song","year":"2024"},{"key":"10.1016\/j.yexcr.2025.114619_bib28","article-title":"Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer","volume":"312","author":"Nguyen","year":"2025"},{"issue":"23","key":"10.1016\/j.yexcr.2025.114619_bib29","doi-asserted-by":"crossref","first-page":"9614","DOI":"10.1158\/0008-5472.CAN-08-0451","article-title":"Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma","volume":"68","author":"Kim","year":"2008","journal-title":"Cancer Res."},{"issue":"17","key":"10.1016\/j.yexcr.2025.114619_bib30","first-page":"2719","article-title":"Nanoparticle\u2010mediated target delivery of TRAIL as gene therapy for glioblastoma","volume":"4","author":"Wang","year":"2015"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114619_bib31","first-page":"1727","article-title":"Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma","volume":"94","author":"Tepper","year":"1999","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib32","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1084\/jem.190.7.1033","article-title":"Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein","volume":"190","author":"Medema","year":"1999","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s10549-007-9563-2","article-title":"Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L)","volume":"107","author":"Guseva","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1097\/01.LAB.0000079328.76631.28","article-title":"Cellular FLICE\/Caspase-8\u2013Inhibitory protein as a principal regulator of cell death and survival in human hepatocellular carcinoma","volume":"83","author":"Okano","year":"2003","journal-title":"Lab. Invest."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib35","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3892\/or.2015.3743","article-title":"Downregulation of SNAIL sensitizes hepatocellular carcinoma cells to TRAIL-induced apoptosis by regulating the NF-\u03baB pathway","volume":"33","author":"Wan","year":"2015","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198203","article-title":"Bcl-2-mediated control of TRAIL-induced apoptotic response in the non-small lung cancer cell line NCI-H460 is effective at late caspase processing steps","volume":"13","author":"Danish","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2025.114619_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-021-01697-6","article-title":"Generation of TRAIL-resistant cell line models reveals distinct adaptive mechanisms for acquired resistance and re-sensitization","author":"Cing\u00f6z","year":"2021","journal-title":"Oncogene"},{"issue":"46","key":"10.1016\/j.yexcr.2025.114619_bib38","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1038\/onc.2008.197","article-title":"A mitochondrial block and expression of XIAP lead to resistance to TRAIL-induced apoptosis during progression to metastasis of a colon carcinoma","volume":"27","author":"Ndozangue-Touriguine","year":"2008","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.yexcr.2025.114619_bib39","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1002\/mc.23253","article-title":"Mcl\u20101 targeting strategies unlock the proapoptotic potential of TRAIL in melanoma cells","volume":"59","author":"Sarif","year":"2020","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib40","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/jcb.29505","article-title":"Targeting BAX ubiquitin-binding sites reveals that BAX activation is essential for its ubiquitin-dependent degradation","volume":"121","author":"Peng","year":"2020","journal-title":"J. Cell. Biochem."},{"issue":"20","key":"10.1016\/j.yexcr.2025.114619_bib41","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1182\/blood.2021014304","article-title":"Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies","volume":"140","author":"Thomalla","year":"2022","journal-title":"Blood"},{"issue":"9\u201310","key":"10.1016\/j.yexcr.2025.114619_bib42","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10495-020-01627-z","article-title":"BAX-dependent mitochondrial pathway mediates the crosstalk between ferroptosis and apoptosis","volume":"25","author":"Lee","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2025.114619_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1327255","article-title":"Reduced expressions of apoptosis-related proteins TRAIL, Bcl-2, and TNFR1 in NK cells of juvenile-onset systemic lupus erythematosus patients: relations with disease activity, nephritis, and neuropsychiatric involvement","volume":"15","author":"Liphaus","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114619_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122733","article-title":"Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer","volume":"312","author":"Nguyen","year":"2025","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1101\/gad.949602","article-title":"TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac\/DIABLO","volume":"16","author":"Deng","year":"2002","journal-title":"Gene Dev."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib46","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00381-010-1087-0","article-title":"Medulloblastoma-derived tumor stem-like cells acquired resistance to TRAIL-induced apoptosis and radiosensitivity","volume":"26","author":"Yu","year":"2010","journal-title":"Childs Nerv. Syst."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib47","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1083\/jcb.200912070","article-title":"Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma","volume":"188","author":"Gillissen","year":"2010","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib48","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.cdd.4402077","article-title":"Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance","volume":"14","author":"Sivaprasad","year":"2007","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13027-017-0139-4","article-title":"LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer","volume":"12","author":"Beyer","year":"2017","journal-title":"Infect. Agents Cancer"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1139\/bcb-2016-0009","article-title":"PKC\u03b1-GSK3\u03b2-NF-\u03baB signaling pathway and the possible involvement of TRIM21 in TRAIL-induced apoptosis","volume":"94","author":"Gao","year":"2016","journal-title":"Biochem. Cell. Biol."},{"issue":"25","key":"10.1016\/j.yexcr.2025.114619_bib51","first-page":"2803","article-title":"TRAIL mediates and sustains constitutive NF-\u03baB activation in LGL leukemia","volume":"131","author":"Yang","year":"2018","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib52","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/sj.onc.1209841","article-title":"NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition","volume":"26","author":"La Ferla-Br\u00fchl","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib53","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7150\/ijbs.30847","article-title":"Andrographolide enhances TRAIL-induced apoptosis via p53-mediated death receptors up-regulation and suppression of the NF-\u043aB pathway in bladder cancer cells","volume":"15","author":"Deng","year":"2019","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib54","doi-asserted-by":"crossref","first-page":"6751","DOI":"10.21873\/anticanres.14698","article-title":"Nitric oxide inhibits NF-\u03baB-mediated survival signaling: possible role in overcoming TRAIL resistance","volume":"40","author":"Bauer","year":"2020","journal-title":"Anticancer Res."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib55","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.3892\/ijo.2016.3751","article-title":"Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN\/PI3K\/Akt\/Bad signaling pathway","volume":"49","author":"Feng","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.yexcr.2025.114619_bib56","first-page":"744","article-title":"[Inhibition of PI3K-Akt pathway reverses LMP1 induced TRAIL resistance in nasopharyngeal carcinoma cell]","volume":"30","author":"Li","year":"2016","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"issue":"65","key":"10.1016\/j.yexcr.2025.114619_bib57","doi-asserted-by":"crossref","first-page":"108665","DOI":"10.18632\/oncotarget.21215","article-title":"Overexpression of miR-101 promotes TRAIL-induced mitochondrial apoptosis in papillary thyroid carcinoma by targeting c-met and MCL-1","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"issue":"42","key":"10.1016\/j.yexcr.2025.114619_bib58","doi-asserted-by":"crossref","first-page":"38361","DOI":"10.1074\/jbc.M103321200","article-title":"Pro-survival function of Akt\/protein kinase B in prostate cancer cells: relationship with trail resistance","volume":"276","author":"Thakkar","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114619_bib59","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2147\/CMAR.S183328","article-title":"Suppression of miR-21-3p enhances TRAIL-mediated apoptosis in liver cancer stem cells by suppressing the PI3K\/Akt\/Bad cascade via regulating PTEN","volume":"11","author":"Zhu","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.yexcr.2025.114619_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.isci.2019.01.015","article-title":"Mathematical modeling highlights the complex role of AKT in TRAIL-induced apoptosis of colorectal carcinoma cells","volume":"12","author":"Anderson","year":"2019","journal-title":"iScience"},{"issue":"59","key":"10.1016\/j.yexcr.2025.114619_bib61","doi-asserted-by":"crossref","first-page":"100021","DOI":"10.18632\/oncotarget.21754","article-title":"Glipizide sensitizes lung cancer cells to TRAIL-induced apoptosis via Akt\/mTOR\/autophagy pathways","volume":"8","author":"Nazim","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib62","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s10495-005-6078-3","article-title":"TRAIL-induced apoptosis in gliomas is enhanced by Akt-inhibition and is independent of JNK activation","volume":"10","author":"Puduvalli","year":"2005","journal-title":"Apoptosis"},{"issue":"10","key":"10.1016\/j.yexcr.2025.114619_bib63","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1158\/1078-0432.CCR-10-2530","article-title":"Targeting aberrant PI3K\/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma","volume":"17","author":"Opel","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib64","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3892\/mmr.2016.5216","article-title":"\u03b2-arrestin2 regulates TRAIL-induced HepG2 cell apoptosis via the Src-extracellular signal-regulated signaling pathway","volume":"14","author":"Qi","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib65","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3892\/or.2020.7662","article-title":"Potentiation of TRAIL-induced cell death by nonsteroidal anti-inflammatory drug in human hepatocellular carcinoma cells through the ER stress-dependent autophagy pathway","volume":"44","author":"Lee","year":"2020","journal-title":"Oncol. Rep."},{"issue":"13","key":"10.1016\/j.yexcr.2025.114619_bib66","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.18632\/oncotarget.2067","article-title":"miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT","volume":"5","author":"Liu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2025.114619_bib67","article-title":"Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal","volume":"4","author":"Eljack","year":"2022","journal-title":"Int. J. Pharm. X"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib68","first-page":"821","article-title":"Icariin sensitizes human colon cancer cells to TRAIL-induced apoptosis via ERK-mediated upregulation of death receptors","volume":"56","author":"Kim","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"19","key":"10.1016\/j.yexcr.2025.114619_bib69","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1038\/sj.onc.1206427","article-title":"Activation of ERK1\/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac\/DIABLO release from mitochondria","volume":"22","author":"Zhang","year":"2003","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114619_bib70","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.febslet.2015.02.026","article-title":"Msi1 confers resistance to TRAIL by activating ERK in liver cancer cells","volume":"589","author":"Liu","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.yexcr.2025.114619_bib71","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.biopha.2016.10.028","article-title":"Pro-survival effects by NF-\u03baB, Akt and ERK (1\/2) and anti-apoptosis actions by Six1 disrupt apoptotic functions of TRAIL-Dr4\/5 pathway in ovarian cancer","volume":"84","author":"Yang","year":"2016","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib72","first-page":"473","article-title":"ERK1\/2-mediated cytoplasmic accumulation of hnRNPK Antagonizes TRAIL-induced apoptosis through upregulation of XIAP in H1299 cells","volume":"30","author":"Huang","year":"2017","journal-title":"Biomed. Environ. Sci."},{"issue":"15","key":"10.1016\/j.yexcr.2025.114619_bib73","doi-asserted-by":"crossref","first-page":"5945","DOI":"10.1074\/jbc.RA118.006029","article-title":"The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6\/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells","volume":"294","author":"Song","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib74","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbrc.2006.10.163","article-title":"Acquired TRAIL resistance in human breast cancer cells are caused by the sustained cFLIPL and XIAP protein levels and ERK activation","volume":"351","author":"Lee","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"32","key":"10.1016\/j.yexcr.2025.114619_bib75","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.A110.191379","article-title":"Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax","volume":"291","author":"Gupta","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib76","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.cellsig.2013.11.033","article-title":"HSP27 phosphorylation modulates TRAIL-induced activation of Src-Akt\/ERK signaling through interaction with \u03b2-arrestin2","volume":"26","author":"Qi","year":"2014","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35908-0","article-title":"Sensitization of renal carcinoma cells to TRAIL-induced apoptosis by rocaglamide and analogs","volume":"8","author":"Nalli","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib78","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/febs.14732","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand reduces the expression of the neuroprotective Na(+)\/Ca(2+) exchanger isoform NCX3 in human neuroblastoma SH-SY5Y cells","volume":"286","author":"Di Benedetto","year":"2019","journal-title":"FEBS J."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114619_bib79","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1080\/09546634.2020.1714541","article-title":"Targeting of keloid with TRAIL and TRAIL-R2\/DR5","volume":"32","author":"Sun","year":"2021","journal-title":"J. Dermatol. Treat."},{"issue":"20","key":"10.1016\/j.yexcr.2025.114619_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012687","article-title":"DR5-Selective TRAIL variant DR5-B functionalized with tumor-penetrating iRGD Peptide for enhanced antitumor activity against glioblastoma","volume":"23","author":"Yagolovich","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib81","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071646","article-title":"Death receptor 5 (TNFRSF10B) is upregulated and TRAIL resistance is reversed in Hypoxia and Normoxia in colorectal cancer cell lines after treatment with Skyrin, the active metabolite of Hypericum spp","volume":"13","author":"Babin\u010d\u00e1k","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/genes12060864","article-title":"Epigenetic modification of death receptor genes for TRAIL and TRAIL resistance in Childhood B-cell Precursor acute lymphoblastic leukemia","volume":"12","author":"Watanabe","year":"2021","journal-title":"Genes"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib83","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s10555-018-9728-y","article-title":"Developing TRAIL\/TRAIL death receptor-based cancer therapies","volume":"37","author":"Yuan","year":"2018","journal-title":"Cancer Metastasis Rev."},{"issue":"34","key":"10.1016\/j.yexcr.2025.114619_bib84","doi-asserted-by":"crossref","first-page":"35829","DOI":"10.1074\/jbc.M405538200","article-title":"Deficient tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis","volume":"279","author":"Jin","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13027-017-0139-4","article-title":"LPS promotes resistance to TRAIL-induced apoptosis in pancreatic cancer","volume":"12","author":"Beyer","year":"2017","journal-title":"Infect. Agents Cancer"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114619_bib86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019679","article-title":"TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT","volume":"6","author":"Lalaoui","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2025.114619_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2017.52","article-title":"TRAIL DR5-CTSB crosstalk participates in breast cancer autophagy initiated by SAHA","volume":"3","author":"Han","year":"2017","journal-title":"Cell Death Discov."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12079-020-00558-3","article-title":"CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells","volume":"14","author":"Li","year":"2020","journal-title":"J. Cell Commun. Signal."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib89","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1158\/1541-7786.MCR-08-0313","article-title":"TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5","volume":"6","author":"Zhang","year":"2008","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3858\/emm.2011.43.1.003","article-title":"Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5","volume":"43","author":"Kang","year":"2011","journal-title":"Experimental & molecular medicine"},{"key":"10.1016\/j.yexcr.2025.114619_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/S2152-2650(20)30903-4","article-title":"IBCL-282: genetic polymorphisms of death receptor 4 (TRAIL-R1) and the susceptibility to B-Non-Hodgkin lymphoma among Egyptians","volume":"20","author":"Khorshied","year":"2020","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib92","doi-asserted-by":"crossref","DOI":"10.3390\/life13020592","article-title":"Santin (5,7-Dihydroxy-3,6,4'-Trimetoxy-Flavone) enhances TRAIL-mediated apoptosis in colon cancer cells","volume":"13","author":"K\u0142\u00f3sek","year":"2023","journal-title":"Life"},{"key":"10.1016\/j.yexcr.2025.114619_bib93","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biocel.2016.07.033","article-title":"Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover","volume":"78","author":"Kim","year":"2016","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"15","key":"10.1016\/j.yexcr.2025.114619_bib94","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2174\/1871520619666190731155859","article-title":"Kaempferol improves TRAIL-mediated apoptosis in leukemia MOLT-4 cells by the inhibition of anti-apoptotic proteins and promotion of death receptors expression","volume":"19","author":"Hassanzadeh","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib95","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3892\/ijo.2013.1926","article-title":"Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation","volume":"43","author":"Lirdprapamongkol","year":"2013","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2025.114619_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105188","article-title":"Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways","volume":"160","author":"Farooqi","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexcr.2025.114619_bib97","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.biopha.2017.01.062","article-title":"Galangin potentiates human breast cancer to apoptosis induced by TRAIL through activating AMPK","volume":"89","author":"Song","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib98","article-title":"Apigenin sensitizes prostate cancer cells to Apo2L\/TRAIL by targeting adenine nucleotide translocase-2","volume":"8","author":"Oishi","year":"2013"},{"key":"10.1016\/j.yexcr.2025.114619_bib99","first-page":"307","volume":"vol. 37","author":"Chevrollier","year":"2005"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib100","first-page":"2071","article-title":"Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma","volume":"37","author":"Lu","year":"2017"},{"key":"10.1016\/j.yexcr.2025.114619_bib101","series-title":"Association of Adenine Nucleotide Translocase 2 (ANT2) with [18F] Fluoro-2-Deoxy-D-Glucose Accumulation in Various Cancers: \uc11c\uc6b8\ub300\ud559\uad50 \ub300\ud559\uc6d0","year":"2018"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib102","first-page":"2571","article-title":"Mitochondrial PAK6 inhibits prostate cancer cell apoptosis via the PAK6-SIRT4-ANT2 complex","volume":"10","author":"Li","year":"2020"},{"key":"10.1016\/j.yexcr.2025.114619_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118637","article-title":"Hyaluronic acid-coated pH sensitive poly (\u03b2-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment","volume":"573","author":"Xu","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib104","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/10717544.2017.1384863","article-title":"TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors","volume":"24","author":"Yang","year":"2017","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib105","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s13287-024-04006-6","article-title":"Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy","volume":"15","author":"Ye","year":"2024","journal-title":"Stem Cell Res. Ther."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib106","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/01616412.2020.1796378","article-title":"TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway","volume":"42","author":"Sur-Erdem","year":"2020","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib107","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s11095-015-1814-z","article-title":"Doxorubicin-bound albumin nanoparticles containing a TRAIL protein for targeted treatment of colon cancer","volume":"33","author":"Thao le","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.yexcr.2025.114619_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119753","article-title":"Oxidative stress-driven DR5 upregulation restores TRAIL\/Apo2L sensitivity induced by iron oxide nanoparticles in colorectal cancer","volume":"233","author":"Shi","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.yexcr.2025.114619_bib109","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.omto.2021.04.004","article-title":"Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer","volume":"21","author":"Vaughan","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib110","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.canlet.2016.10.005","article-title":"High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer","volume":"383","author":"De Miguel","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2025.114619_bib111","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.actbio.2022.03.001","article-title":"TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy","volume":"143","author":"Feng","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.yexcr.2025.114619_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116603","article-title":"Intratumoural delivery of TRAIL mRNA induces colon cancer cell apoptosis","volume":"174","author":"Gu","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib113","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1021\/acsnano.7b05876","article-title":"Nanoparticles for immune cytokine TRAIL-based cancer therapy","volume":"12","author":"Guimar\u00e3es","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.yexcr.2025.114619_bib114","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.2147\/IJN.S129274","article-title":"Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells","volume":"12","author":"Ke","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib115","first-page":"45","article-title":"TRAIL conjugated silver nanoparticle Synthesis, characterization and therapeutic effects on HT-29 colon cancer cells","volume":"20","author":"Birtekocak","year":"2021","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"issue":"18","key":"10.1016\/j.yexcr.2025.114619_bib116","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/27\/18\/185101","article-title":"TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells","volume":"27","author":"De Miguel","year":"2016","journal-title":"Nanotechnology"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib117","first-page":"149","article-title":"Polymeric nanoparticle\u2010based delivery of TRAIL DNA for cancer\u2010specific killing","volume":"1","author":"Tzeng","year":"2016"},{"key":"10.1016\/j.yexcr.2025.114619_bib118","first-page":"1","article-title":"Mitoxantrone-loaded PLGA nanoparticles for increased sensitivity of glioblastoma cancer cell to TRAIL-induced","author":"Hashemi","year":"2022","journal-title":"Apoptosis"},{"key":"10.1016\/j.yexcr.2025.114619_bib119","first-page":"615","volume":"vol. 33","author":"Thao","year":"2016"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib120","first-page":"506","article-title":"Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer","volume":"494","author":"Min","year":"2015"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib121","first-page":"1526","article-title":"TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors","volume":"24","author":"Yang","year":"2017"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib122","first-page":"92","article-title":"Pharmacokinetic\u2014pharmacodynamic modeling of tumor targeted drug delivery using nano-engineered mesenchymal","volume":"13","author":"Cheng","year":"2021","journal-title":"stem cells"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114619_bib123","first-page":"759","article-title":"Formulations, pharmacodynamic and clinical studies of nanoparticles for lung cancer therapy-an overview","volume":"19","author":"Zheng","year":"2018"},{"issue":"13","key":"10.1016\/j.yexcr.2025.114619_bib124","first-page":"3538","article-title":"Improved biological half-life and anti-tumor activity of TNF-related apoptosis-inducing ligand (TRAIL) using PEG-exposed nanoparticles","volume":"32","author":"Lim","year":"2011"},{"issue":"37","key":"10.1016\/j.yexcr.2025.114619_bib125","first-page":"13879","article-title":"Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy","volume":"9","author":"Wu","year":"2017"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/stcltm\/szab031","article-title":"Site-specific Integration of TRAIL in iPSC-derived mesenchymal stem cells for targeted cancer therapy","volume":"11","author":"Wang","year":"2022","journal-title":"Stem Cells Transl. Med."},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib127","first-page":"860","article-title":"Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy","volume":"18","author":"Yuan","year":"2016","journal-title":"Cytopathology (Oxf.)"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib128","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3892\/or.2021.7937","article-title":"Combination treatment with VPA and MSCs-TRAIL could increase anti-tumor effects against intracranial glioma","volume":"45","author":"Park","year":"2021","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13287-020-01770-z","article-title":"Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with (89)Zr-oxine PET-CT","volume":"11","author":"Patrick","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.yexcr.2025.114619_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.699746","article-title":"Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges","volume":"12","author":"Razeghian","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.yexcr.2025.114619_bib131","article-title":"Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma","volume":"5","author":"Grisendi","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib132","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1007\/s13277-015-3058-2","article-title":"Bypassing the need for pre-sensitization of cancer cells for anticancer TRAIL therapy with secretion of novel cell penetrable form of Smac from hA-MSCs as cellular delivery vehicle","volume":"36","author":"Khorashadizadeh","year":"2015","journal-title":"Tumour Biol"},{"issue":"11","key":"10.1016\/j.yexcr.2025.114619_bib133","article-title":"Chemo-sensitization of CD133+ cancer stem cell enhances the effect of mesenchymal stem cell expressing TRAIL in non-small cell lung cancer cell lines","volume":"10","author":"Fakiruddin","year":"2021","journal-title":"Biology (Basel)"},{"issue":"9","key":"10.1016\/j.yexcr.2025.114619_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091261","article-title":"Targeting of CD133+ cancer stem cells by mesenchymal stem cell expressing TRAIL reveals a prospective role of apoptotic gene regulation in non-small cell lung cancer","volume":"11","author":"Fakiruddin","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.yexcr.2025.114619_bib135","article-title":"Mesenchymal stem cell expressing TRAIL as targeted therapy against Sensitised tumour","volume":"19","author":"Fakiruddin","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2025.114619_bib136","article-title":"Paclitaxel priming of TRAIL expressing mesenchymal stromal cells (MSCs-TRAIL) increases antitumor efficacy of their secretome","author":"Cocc\u00e8","year":"2020","journal-title":"Curr. Cancer Drug Targets"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib137","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/ijc.30402","article-title":"TRAIL delivered by mesenchymal stromal\/stem cells counteracts tumor development in orthotopic Ewing sarcoma models","volume":"139","author":"Guiho","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib138","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/cgt.2010.68","article-title":"TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo","volume":"18","author":"Mueller","year":"2011","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexcr.2025.114619_bib139","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2021.101664","article-title":"Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-\u03b21 can kill carcinoma cancer cells","volume":"73","author":"Chulpanova","year":"2021","journal-title":"Tissue Cell"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib140","first-page":"71","article-title":"Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer","volume":"163","author":"Ozawa","year":"2001"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib141","first-page":"77","article-title":"Should we keep walking along the trail for pancreatic cancer treatment? Revisiting TNF-related apoptosis-inducing ligand for anticancer therapy","volume":"10","author":"Kretz","year":"2018"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib142","first-page":"1788","article-title":"Soluble TRAIL armed human MSC as gene therapy for pancreatic cancer","volume":"9","author":"Spano","year":"2019"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib143","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/s41598-018-37433-6","article-title":"Soluble TRAIL armed human MSC as gene therapy for pancreatic cancer","volume":"9","author":"Spano","year":"2019","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib144","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4161\/cbt.21347","article-title":"The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2012","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.7150\/thno.27576","article-title":"MSC-delivered soluble TRAIL and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma","volume":"9","author":"Rossignoli","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.yexcr.2025.114619_bib146","series-title":"Mesenchymal Stem Cell 1 (MSC1)-Based Therapy Attenuates Tumor Growth whereas MSC2-Treatment Promotes Tumor Growth and Metastasis","author":"Waterman","year":"2012"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib147","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41419-023-06417-4","article-title":"The E3 ubiquitin ligase Itch regulates death receptor and cholesterol trafficking to affect TRAIL-mediated apoptosis","volume":"15","author":"Holloway","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114619_bib148","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.gene.2017.06.055","article-title":"MiR-126 reverses drug resistance to TRAIL through inhibiting the expression of c-FLIP in cervical cancer","volume":"627","author":"Zhang","year":"2017","journal-title":"Gene (Amst.)"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib149","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/0929866530666230112165515","article-title":"GSK3\u03b2\/ITCH\/c-FLIP Axis counteracts TRAIL-induced apoptosis in human lung adenocarcinoma cells","volume":"30","author":"Zheng","year":"2023","journal-title":"Protein Pept. Lett."},{"issue":"5","key":"10.1016\/j.yexcr.2025.114619_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050656","article-title":"Countering TRAIL resistance in melanoma","volume":"11","author":"Eberle","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.yexcr.2025.114619_bib151","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1016\/j.bmc.2015.05.044","article-title":"Sesquiterpenes with TRAIL-resistance overcoming activity from Xanthium strumarium","volume":"23","author":"Karmakar","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.yexcr.2025.114619_bib152","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biocel.2016.12.001","article-title":"Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage","volume":"83","author":"Park","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"30","key":"10.1016\/j.yexcr.2025.114619_bib153","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1038\/s41388-018-0265-5","article-title":"Hypertonicity-enforced BCL-2 addiction unleashes the cytotoxic potential of death receptors","volume":"37","author":"Sirtl","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.yexcr.2025.114619_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061661","article-title":"TRAIL\/NF-\u03baB\/CX3CL1 mediated onco-immuno crosstalk leading to TRAIL resistance of pancreatic cancer cell lines","volume":"19","author":"Geismann","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41419-022-05535-9","article-title":"NF-\u03baB\/RelA controlled A20 limits TRAIL-induced apoptosis in pancreatic cancer","volume":"14","author":"Geismann","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib156","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jcb.27575","article-title":"Apigenin as an effective anticancer natural product: Spotlight on TRAIL, WNT\/\u03b2-catenin, JAK-STAT pathways, and microRNAs","volume":"120","author":"Ozbey","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib157","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s12013-014-0444-0","article-title":"Kurarinone synergizes TRAIL-induced apoptosis in gastric cancer cells","volume":"72","author":"Zhou","year":"2015","journal-title":"Cell Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.yexcr.2025.114619_bib158","first-page":"941","article-title":"Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis","volume":"38","author":"Szliszka","year":"2011","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms11010001","article-title":"Chalcones enhance TRAIL-induced apoptosis in prostate cancer cells","volume":"11","author":"Szliszka","year":"2009","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib160","first-page":"2000","article-title":"The combination of TRAIL and isoflavones enhances apoptosis in cancer cells","volume":"15","author":"Bronikowska","year":"2010"},{"issue":"2","key":"10.1016\/j.yexcr.2025.114619_bib161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055922","article-title":"Apigenin sensitizes prostate cancer cells to Apo2L\/TRAIL by targeting adenine nucleotide translocase-2","volume":"8","author":"Oishi","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib162","doi-asserted-by":"crossref","first-page":"9970","DOI":"10.18632\/oncotarget.3667","article-title":"Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage","volume":"6","author":"Ko","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.yexcr.2025.114619_bib163","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.bbrc.2018.01.003","article-title":"Irigenin sensitizes TRAIL-induced apoptosis via enhancing pro-apoptotic molecules in gastric cancer cells","volume":"496","author":"Xu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt B","key":"10.1016\/j.yexcr.2025.114619_bib164","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jconrel.2015.09.014","article-title":"Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors","volume":"220","author":"Oh","year":"2015","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.yexcr.2025.114619_bib165","first-page":"1061","article-title":"TRAIL-conjugated silver nanoparticles sensitize glioblastoma cells to TRAIL by regulating CHK1 in the DNA repair pathway","volume":"42","author":"Sur-Erdem","year":"2020"},{"issue":"1","key":"10.1016\/j.yexcr.2025.114619_bib166","first-page":"141","article-title":"Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle\u2013mediated gene expression","volume":"9","author":"Miao","year":"2013"},{"issue":"5","key":"10.1016\/j.yexcr.2025.114619_bib167","first-page":"1449","article-title":"Lipid nanoparticles decorated with TNF-related aptosis-inducing ligand (TRAIL) are more cytotoxic than soluble recombinant TRAIL in sarcoma","volume":"19","author":"Gallego-Lleyda","year":"2018"},{"key":"10.1016\/j.yexcr.2025.114619_bib168","first-page":"663","volume":"vol. 69","author":"Miao","year":"2014"},{"key":"10.1016\/j.yexcr.2025.114619_bib169","series-title":"Ionizable Lipid Nanoparticle-Mediated TRAIL mRNA Delivery in the Tumor Microenvironment to Inhibit Colon Cancer Progression","first-page":"2655","author":"da Silva","year":"2024"},{"issue":"7","key":"10.1016\/j.yexcr.2025.114619_bib170","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/s41419-022-05069-0","article-title":"Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade","volume":"13","author":"Huang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6b","key":"10.1016\/j.yexcr.2025.114619_bib171","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1111\/j.1582-4934.2008.00317.x","article-title":"Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model","volume":"12","author":"Mohr","year":"2008","journal-title":"J. Cell Mol. Med."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725002150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725002150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T23:58:13Z","timestamp":1749340693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725002150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":171,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0014482725002150"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114619","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond TRAIL resistance: Novel strategies for potentiating TRAIL-induced apoptosis in cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114619"}}